Cupid Ltd (CUPID.NS) Hits ₹226 High After Q1 Revenue Boost on July 9

Cupid Ltd’s shares climbed to a fresh 52-week high of ₹226 on Wednesday after the condom and personal care manufacturer raised its FY27 revenue guidance to over ₹660 crore, up from ₹600 crore. The stock jumped 2% on Wednesday and has gained 19% this month after the company reported Q1 revenue tracking above ₹150 crore, one of its strongest quarters ever.

Why the stock jumped after Q1 update

Cupid released a provisional business update on June 30 showing Q1 FY27 revenue on track to exceed ₹150 crore. The company attributed this strength to diversified product sales, expanding global opportunities, and increased operating scale across multiple business verticals. Management also noted steady progress in its In Vitro Diagnostics segment. The stock advanced in five of the last six trading sessions following the announcement, with only a July 2 decline breaking the rally.

Revenue guidance raised by 10%

The company revised its full-year FY27 revenue target upward by at least 10%, now expecting ₹660 crore or more versus the prior ₹600 crore forecast. This revision reflects confidence in both domestic and international demand. Cupid manufactures and supplies male and female condoms, water-based lubricants, and IVD kits from its facility near Nashik, 200 km from Mumbai. The company holds WHO and UN Population Fund prequalification for both male and female condom supply.

Massive gains over multiple timeframes

Cupid shares have delivered extraordinary returns. Over the past year, the stock has surged 940%, while year-to-date gains stand at 114%. In just three years, shares have climbed 9,155%. Over the last three months alone, the stock jumped 144%. Meyka rates the stock B+ with a neutral recommendation, citing a strong 70.1 grade driven by sector outperformance and solid fundamentals. However, the valuation remains stretched: the PE ratio sits at 246.84, and the price-to-sales ratio is 74.05, both well above typical consumer defensive benchmarks.

Valuation concerns temper the rally

While Meyka’s 12-month price forecast of ₹278.09 suggests modest upside from current levels near ₹197, the stock’s extreme valuations warrant caution. The PE ratio of 246.84 and price-to-book of 58.68 rank among the highest in the sector. Meyka’s DCF analysis scores the stock 2 out of 5, recommending a sell on intrinsic value grounds. Strong ROE (27.8%) and ROA (19.6%) support growth, but the cash conversion cycle of 194 days and inventory turnover of 2.26x indicate operational challenges. RSI at 65.14 signals overbought conditions, though ADX at 42.12 confirms a strong uptrend remains intact.

Final Thoughts

Cupid’s Q1 beat and raised guidance justify the recent rally, but valuations have stretched far ahead of fundamentals. With Meyka grading the stock B+ and forecasting ₹278.09 over 12 months, the risk-reward now tilts toward caution despite the company’s strong growth trajectory.

FAQs

Disclaimer:

The content shared by Meyka AI PTY LTD is solely for research and informational purposes.  Meyka is not a financial advisory service, and the information provided should not be considered investment or trading advice.